---
title: Merck KGaA vs Roquette Pharma Solutions
slug_a: merck-kgaa
slug_b: roquette
site: cdmo
review_signal_gate: closed
canonical_path: /compare/merck-kgaa/roquette
---

# Merck KGaA vs Roquette Pharma Solutions

Side-by-side profile data from each company listing on this directory.

## Merck KGaA

- Profile: [/companies/merck-kgaa](/companies/merck-kgaa)

Merck KGaA — Recent coverage reports that Merck KGaA plans to sell its life science CDMO business to Lonza. The same coverage describes a new €300 million bioprocessing center in Daejeon, South Korea.

Services: 0. Modalities: 0. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in locations (1).

### Services

- Data not yet provided.

### Modalities

- Data not yet provided.

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Data not yet provided.

## Roquette Pharma Solutions

- Profile: [/companies/roquette](/companies/roquette)

Roquette Pharma Solutions — Roquette is a leading global provider of plant-based ingredients, excipients, and solutions for the pharmaceutical and healthcare industries.

Services: 4. Modalities: 1. Indications: 0. Locations: 30. Certifications: 1. The strongest documented coverage currently appears in locations (30).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Formulation Development
- CMC Analytical Development

### Modalities

- Small Molecule

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)